Literature DB >> 18688658

[Pain and neuroborreliosis: significance, diagnosis and treatment].

T A Rupprecht1, T Birnbaum, H-W Pfister.   

Abstract

Lyme neuroborreliosis is a tick-borne infection of the central nervous system caused by the spirochete Borrelia burgdorferi. The most frequent manifestation of neuroborreliosis in Europe is meningoradiculitis or Bannwarth's syndrome. One of its hallmarks is intense, lancinating, radicular pain, especially at night. Its characteristics are rather different to other forms of neuropathic pain in respect to the dynamics, localisation and therapeutic responses. This review therefore summarises not only the general symptoms, diagnostic procedures and therapy of Lyme neuroborreliosis, but also revises the characteristics and therapeutic options of painful meningoradiculitis in Bannwarth's syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688658     DOI: 10.1007/s00482-008-0695-z

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  13 in total

Review 1.  Pharmacologic management of neuropathic pain: evidence-based recommendations.

Authors:  Robert H Dworkin; Alec B O'Connor; Miroslav Backonja; John T Farrar; Nanna B Finnerup; Troels S Jensen; Eija A Kalso; John D Loeser; Christine Miaskowski; Turo J Nurmikko; Russell K Portenoy; Andrew S C Rice; Brett R Stacey; Rolf-Detlef Treede; Dennis C Turk; Mark S Wallace
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

2.  The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.

Authors:  T A Rupprecht; H W Pfister; B Angele; S Kastenbauer; B Wilske; U Koedel
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

3.  Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases.

Authors:  J M Vallat; J Hugon; M Lubeau; M J Leboutet; M Dumas; R Desproges-Gotteron
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

4.  Incidence of Lyme borreliosis in the Würzburg region of Germany.

Authors:  H I Huppertz; M Böhme; S M Standaert; H Karch; S A Plotkin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-10       Impact factor: 3.267

5.  The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production.

Authors:  K Hansen; A M Lebech
Journal:  Brain       Date:  1992-04       Impact factor: 13.501

Review 6.  Lyme neuroborreliosis in children.

Authors:  H J Christen
Journal:  Ann Med       Date:  1996-06       Impact factor: 4.709

7.  Pain as presenting symptom in Lyme neuroborreliosis.

Authors:  Leif Dotevall; Tore Eliasson; Lars Hagberg; Clas Mannheimer
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

8.  Headache resembling tension-type headache as the single manifestation of Lyme neuroborreliosis.

Authors:  T Brinck; K Hansen; J Olesen
Journal:  Cephalalgia       Date:  1993-06       Impact factor: 6.292

9.  Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E D Shapiro; E Logigian; A L Belman; L Dotevall; G P Wormser; L Krupp; G Gronseth; C T Bever
Journal:  Neurology       Date:  2007-05-23       Impact factor: 9.910

10.  Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study.

Authors:  H W Pfister; V Preac-Mursic; B Wilske; K M Einhäupl
Journal:  Arch Neurol       Date:  1989-11
View more
  1 in total

1.  Multidisciplinary Management of Suspected Lyme Borreliosis: Clinical Features of 569 Patients, and Factors Associated with Recovery at 3 and 12 Months, a Prospective Cohort Study.

Authors:  Alice Raffetin; Julien Schemoul; Amal Chahour; Steve Nguala; Pauline Caraux-Paz; Giulia Paoletti; Anna Belkacem; Fernanda Medina; Catherine Fabre; Sébastien Gallien; Nicolas Vignier; Yoann Madec
Journal:  Microorganisms       Date:  2022-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.